CSPC Pharmaceutical Group Ltd (01093.HK) saw its stock price surge by 7.61% during Friday's trading session, following news of potential major transactions. The Hong Kong-listed pharmaceutical company announced that it is currently in negotiations with independent third parties regarding three significant deals.

According to a statement from CSPC Pharmaceutical, the potential transactions under discussion could amount to an impressive US$5 billion in aggregate. This substantial figure has caught the attention of investors, driving the stock's remarkable intraday performance.

While specific details about the nature of these transactions remain undisclosed, the sheer scale of the potential deals suggests they could have a significant impact on CSPC Pharmaceutical's future growth and market position. The pharmaceutical sector has been seeing increased activity in mergers, acquisitions, and strategic partnerships, as companies seek to expand their product portfolios and research capabilities.